Getting Stoned Without Inhaling: Anandamide Is the Brain's Natural Marijuana
J Clin Psychiatry 1998;59(11):566-567
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
The brain makes its own morphine, so why not its own marijuana? Marijuana has been in use for over 4000 years as both a therapeutic agent and a recreational drug. Until 10 years ago, however, the exact mechanism of marijuana’s psychoactive properties was relatively obscure, even though the psychoactive ingredient has long been known to be delta-9-tetrahydrocannabinol (THC). Analogous to how the endogenous opiates were discovered, isolation and characterization of cannabinoid (CB) receptors provided the key for their use as a tool in isolating an endogenous ligand for marijuana receptors in the brain.